PB
Priscilla K. Brastianos
Elite in Metastatic Brain Tumor
Check Dr. Priscilla K. Brastianos' experience treating your condition:
About Dr. Priscilla K. Brastianos

Priscilla Brastianos is an Oncologist and a Hematologist Oncology expert in Boston, Massachusetts. Brastianos has been practicing medicine for over 16 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 27 other conditions, according to our data. Her top areas of expertise are Metastatic Brain Tumor, Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Gamma Knife Radiosurgery. She is licensed to treat patients in Massachusetts. Brastianos is currently accepting new patients.

Her clinical research consists of co-authoring 167 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, she has co-authored 34 articles and participated in 2 clinical trials in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Priscilla K. Brastianos it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
55 Fruit St, Boston, MA 02114
Background & Education
Graduate Institution
Johns Hopkins University School Of Medicine, 2006
Specialties
Oncology
Hematology Oncology
Licenses
Internal Medicine in MA
Hospital Affiliations
Wentworth-Douglass Hospital
Brigham And Womens Hospital
Massachusetts General Hospital
North Shore Medical Center - Salem Hospital
Languages Spoken
English
French
Greek
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
Genomically Guided Phase II Study to Evaluate the Clinical Benefit of Niraparib in Tumors Metastatic to the CNS
Phase II Trial of Pembrolizumab in Central Nervous System Metastases From Multiple Histologies
Genomically-Guided Treatment Trial in Brain Metastases
A Phase 2 Study of Palbociclib in Progressive Brain Metastases Harboring Alterations in the CDK Pathway
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
Phase II Trial of Ipilimumab and Nivolumab in Leptomeningeal Metastases
View 2 Less Clinical Trial -

165 Total Publications

Emerging systemic treatment options in meningioma.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Distinguished